Evidence map›Paper›PMID 39095493›Full record

ArticleNPJ breast cancer2024

Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.

Simone Scagnoli, Simona Pisegna, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo de Giorgi, Enrico Cortesi, Agnese Fabbri, Alessandra Fabi and 22 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ breast cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

32 authors.

Simone ScagnoliDepartment of Radiological, Oncological and Pathological Science, "Sapienza" University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0003-4943-5622
Simona PisegnaDepartment of Experimental Medicine, Sapienza University, Rome, Italy. simona.pisegna@uniroma1.it.ORCID http://orcid.org/0000-0002-6910-9528
Angela TossDepartment of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
Roberta CaputoDepartment of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy.ORCID http://orcid.org/0000-0003-4231-1184
Michelino De LaurentiisDepartment of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy.ORCID http://orcid.org/0000-0001-9009-1572
Michela PalleschiIRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST Meldola IT, Meldola, Italy.
Ugo de GiorgiIRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST Meldola IT, Meldola, Italy.
Enrico CortesiDepartment of Radiological, Oncological and Pathological Science, "Sapienza" University of Rome, Rome, Italy.
Agnese FabbriUOC Belcolle Hospital, Viterbo, Italy.
Alessandra FabiPrecision Medicine in Senology, Department of Women Child and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-0758-8033
Ida ParisDivision of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-7445-3366
Armando OrlandiFondazione Policlinico Universitario Agostino Gemelli IRCCS Comprehensive Cancer Center, Unit of Medical Oncology, Rome, Italy.
Giuseppe CuriglianoDivision of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0003-1781-2518
Carmen CriscitielloDivision of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
Ornella GarroneFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, SC Oncologia Medica, Milan, Italy.
Gianluca TomaselloFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, SC Oncologia Medica, Milan, Italy.
Giuliana D'AuriaSandro Pertini Hospital Unit of Medical Oncology, Rome, Italy.
Patrizia ViciIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori Regina Elena, UOSD Sperimentazioni di fase IV IT, Rome, Italy.
Enrico RicevutoUniversity of L'Aquila, L'Aquila, Italy.ORCID http://orcid.org/0000-0001-5641-3187
Federica DomatiDepartment of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Claudia PiombinoDepartment of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.ORCID http://orcid.org/0000-0002-7224-4536
Sara ParolaDepartment of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy.
Roberta ScafettaUniversità Campus Biomedico, Rome, Italy.
Alessio CirilloDepartment of Radiological, Oncological and Pathological Science, "Sapienza" University of Rome, Rome, Italy.
Beatrice Taurelli SalimbeniDivision of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
Francesca Sofia Di LisaIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori Regina Elena, UOSD Sperimentazioni di fase IV IT, Rome, Italy.
Lidia StrigariIRCSS AOU Bologna, Bologna, Italy.ORCID http://orcid.org/0000-0003-4293-2298
Robert PreissnerInstitute of Physiology and Science-IT, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Maurizio SimmacoLaboratory of Clinical Biochemistry, Sant'Andrea University Hospital, Rome, Italy.
Daniele SantiniDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.
Paolo MarchettiIstituto Dermopatico dell'Immacolata IRCCS, Rome, Italy.
Andrea BotticelliDepartment of Radiological, Oncological and Pathological Science, "Sapienza" University of Rome, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39095493
PMCPMC11297323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.